VRNA (veronapharma.com) Bozor qiymatining balans qiymatiga nisbati
Verona Pharma plc (VRNA) kelajagi o'zining yagona tasdiqlangan respirator agentining muvaffaqiyatli bozorga chiqarilishiga asoslangan. Bozor kapitalizatsiyasining sof aktivlar nisbatini ko'rsatuvchi ushbu grafik bozor premiumini vizuallashtiradi, bunda 32.84 ko'rsatkichi metrikaning holatini ifodalaydi. Biznesni rivojlantirish global tarmoqlar bilan strategik ittifoqlarga tayanadi, AQSh va Yevropadagi neytral geosiyosiy fon esa tashqi xavflarni minimallashtiradi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_VRNA_-_Verona-Pharma-plc_-_Market-Capitalization-to-Net-Assets "VRNA Verona Pharma Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 18.10.2025) | 👁️GURU.Markets👁️")
Verona Pharma PLC (VRNA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Verona Pharma plc|VRNA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Verona Pharma Corp|VRNA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Verona Pharma Corp|VRNA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Verona Pharma
Kompaniyaning dastlabki tahlili:Verona Pharma plc - VRNA
Emitentning moliyaviy barqarorligini baholash uchun bozor kapitalizatsiyasining sof aktivlar qiymatiga nisbati ishlatiladi, bu esa biznesning balans qiymatidan yuqori bozor premiumini ko'rsatadi. Bozor qiymatining kapitalga nisbatidagi o'zgarishini tahlil qilish orqali investor Verona Pharma (VRNA) kompaniyasining respirator patologiyalarni davolash uchun innovatsion dori vositalariga bo'lgan kutishlar kompaniyaning haqiqiy moddiy aktivlariga nisbatan uning baholanishiga qanday ta'sir qilishini ko'rishi mumkin.
Asosiy raqobatchilar
HLN: Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Jyong Biotech MENS|Sof aktivlarga nisbatan bozor kapitallashuvi Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Perrigo Corp (PRGO)|Bozor kapitallashuvining balans qiymatiga nisbati ALVO (Alvotech)|liquidia.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Galapagos (GLPG)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com HYFT|Kapitallashuvning sof aktivlarga nisbati ABVC BioPharma, Inc. ABVC|Bozor qiymatining balans qiymatiga nisbati Cumberland Pharmaceuticals Inc CPIX|QNTM (Quantum BioPharma Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals TELO|RANI (Rani Therapeutics Holdings, Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati SNYR (Synergy CHC Corp.)|Bozor qiymatining balans qiymatiga koeffitsiyenti RLYB|Bozor qiymatining balans qiymatiga nisbati Lexaria Bioscience LEXX|Kapitallashuvning balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati PTHL (Pheton Holdings)|APM - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics (LYRA)|IBO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati tnfpharma.com (TNFA)|cbdMD (YCBD) - Sof aktivlarga nisbatan bozor kapitallashuvi|PRFX - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OPTN (OptiNose Inc)|Bozor qiymatining balans qiymatiga nisbati Pieris|Procaps Group Corp - Balans qiymatiga nisbatan bozor qiymati|PTPI: Bozor qiymatining balans qiymatiga nisbati|QLI - Kapitallashuvning sof aktivlarga nisbati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TFF Pharmaceuticals Inc.